Palvella Therapeutics, Inc. Property, Plant and Equipment, Gross
Palvella Therapeutics, Inc. (PVLA) had Property, Plant and Equipment, Gross of $26.68 million as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2024-03-29
- 2023-06-30: Property, Plant and Equipment, Gross $26.68M.
- 2023-03-31: Property, Plant and Equipment, Gross $26.68M.
- 2022-12-31: Property, Plant and Equipment, Gross $26.64M.
- 2022-09-30: Property, Plant and Equipment, Gross $24.22M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2023-06-30 | $26.68M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $26.68M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $26.64M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $24.22M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $25.68M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $27.03M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $26.84M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $26.90M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $27.23M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $26.68M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $27.86M 10-K · filed 2022-03-02 | |
| 2020-09-30 | $26.29M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $24.67M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $24.02M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $23.07M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $14.40M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $11.24M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $8.17M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $8.41M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $7.99M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $7.79M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $7.65M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $6.91M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $4.69M 10-K · filed 2018-03-15 | $4.69M 10-K · filed 2017-03-30 |
| 2015-12-31 | $4.45M 10-K · filed 2017-03-30 | |
| 2014-12-31 | $4.23M 10-K · filed 2016-03-23 | |
| 2013-12-31 | $4.54M 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |